24 May 2013
Keywords: novartis, submits, xolair, japanese, clearance, swiss, drug
Article | 03 July 2006
Swiss drug major Novartis has submitted an application to the Japanese health authorities for the approval of Xolair (omalizumab), its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
3 July 2006
23 May 2013
© 2013 thepharmaletter.com